Tunstall's key focus at the event is its 5 Steps to Telehealth Success programme, a robust implementation process which helps health providers to ensure that telehealth is deployed successfully to the right patients, and embedded within care pathways. Tunstall provides dedicated, clinical support throughout the telehealth journey, from engagement to deployment and governance.

The 5 step approach covers care pathway optimisation, patient identification and risk stratification, clinical review and care planning, referral generation, and post-deployment review and support. This ensures positive outcomes for patients and clinicians, and accelerates financial returns.

Tunstall will also be demonstrating its latest mymedic II home telehealth system, which is designed to help people with long-term health needs to monitor their own conditions from home. The device enables users to easily self-monitor their vital signs to ensure timely intervention, while enhancing understanding of their health.

Designed specifically for the needs of patients with poor dexterity and eyesight, the system's touchscreen tablet design gives easy access to functions and offers limitless flexibility for future applications, while Bluetooth technology makes the process of sharing information faster and more efficient. New peripherals for mymedic II include a blood pressure monitor, pulse oximeter and weighing scales, enabling the solution to help manage a range of long-term conditions.

Tunstall is working together with risk stratification provider Health Intelligence to enhance and support the delivery of its fully managed telehealthcare service, Tunstall LifeCare. A proven risk stratification process is essential for delivering an effective telehealthcare service at scale, as it identifies the most appropriate patients for the service, accelerating benefits to service users and maximising care provision and ROI for the provider.

Tunstall LifeCare and Health Intelligence’s population-based Risk Stratification and Case Finding modules offer local commissioners a robust, secure and rapidly deployable solution that helps the NHS to improve diagnosis, promote prevention and deliver cost savings.

David Cockayne, Managed Services Director said: "For telehealth programmes to be truly successful at scale, it's important that each patient is carefully selected based on specific criteria and thresholds. Commissioning 2013 is a great opportunity for us to showcase how our advanced solutions and services and our partnership with Health Intelligence can help commissioners and clinicians in identifying the patients who will benefit most from telehealth, and deliver the most positive outcomes for patients, clinicians and commissioners."

Related news articles:

• Tunstall's Profile

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.